Navigation Links
Confronting Influenza: Are We Prepared?

"Confronting Influenza: Are We Prepared?" A Symposium Presented by The Howard Hughes Medical Institute and The Center for Strategic and International Studies.

The Howard Hughes Medical Institute (HHMI) and the Center for Strategic and International Studies (CSIS) cordially invite you to attend a symposium on the current state of research, development of prophylactic and therapeutic treatments, and U.S. and global strategies aiming to manage both annual and possible global pandemic influenza outbreaks.

World-renowned speakers will include:

  • Stephen C. Harrison, HHMI Investigator and Professor of Biological Chemistry and Molecular Pharmacology, Professor of Pediatrics and Director of the Harvard-Armenise Center for Structural Biology at Harvard Medical School; and Head of the Laboratory of Molecular Medicine at Children's Hospital, Boston;
  • Dominick A. Iacuzio, Medical Director at Hoffman-La Roche, Inc;
  • Robert A. Lamb, HHMI Investigator and John Evans Professor of Molecular and Cellular Biology at Northwestern University, Evanston, and Professor of Microbiology-Immunology at Northwestern University Medical School;
  • Peter Palese, Chairman and Professor, Department of Microbiology, Mt. Sinai School of Medicine;
  • Timothy M. Uyeki, Medical Epidemiologist, Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention; and
  • Robert G. Webster, Rose Marie Thomas Chair, Division of Virology, St. Jude Children's Research Hospital; Consultant to the World Health Organization (WHO) and the National Institute of Allergy and Infectious Diseases (NIAID); and Director of the U.S. Collaborating Center of the WHO dealing with the ecology of animal influenza viruses.

    Discussion topics will include the structure of the influenza viral proteins and the relevance of that structure for drug development, lessons learned from the 1918 pandemic, current H5N1 (Avia n influenza) developments in Asia, the state of U.S. preparedness and influenza surveillance, and the private sector's views on drug development.


    '"/>


  • Source:Howard Hughes Medical Institute


    Related biology news :

    1. RNA project to create language for scientists worldwide
    2. Disease diagnosis, biodefense among UH chemical research projects
    3. New project aims to make large-scale lobster farms feasible
    4. New Scripps Oceanography project to study sediments and ecosystem restoration in Venice lagoon
    5. ‘Blue Brain?project explores thought at molecular level
    6. Grand Challenges in Global Health initiative funds Yale project
    7. Virtual microscopy project wins educational technology award
    8. St. Jude projects 90 percent cure rate for ALL
    9. UCLA study of community health project shows how group dynamics affect fitness, eating habits
    10. Large-scale genomics project will hunt genes behind common childhood diseases
    11. Ground spider diversity studied in research project
    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
    (Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
    (Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
    Breaking Biology News(10 mins):
    (Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
    (Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
    (Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of ... award for Excellence in Volunteer Experience from US2020. , US2020’s mission is to ...
    (Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
    Breaking Biology Technology: